MARKET

SCPH

SCPH

scPharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.75
-0.46
-7.41%
Closed 16:00 10/18 EDT
OPEN
6.32
PREV CLOSE
6.21
HIGH
6.46
LOW
5.75
VOLUME
82.93K
TURNOVER
--
52 WEEK HIGH
7.85
52 WEEK LOW
2.440
MARKET CAP
106.84M
P/E (TTM)
-3.9774
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SCPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SCPH News

  • HC Wainwright & Co. Initiates Coverage On scPharmaceuticals with Buy Rating, Announces $13 Price Target
  • Benzinga.5d ago
  • 52 Biggest Movers From Yesterday
  • Benzinga.10/02 08:22
  • Winning Bounce/Lag Momentum Stocks For Week 40 Of 2019 - 9/30-10/4
  • Seeking Alpha - Article.09/30 21:43
  • Winning Bounce/Lag Momentum Stocks For Week 39 Of 2019 - 9/23-9/27
  • Seeking Alpha - Article.09/24 06:51

More

Industry

Medical Equipment, Supplies & Distribution
+0.02%
Healthcare Equipment & Supplies
+0.23%

Hot Stocks

Name
Price
%Change

About SCPH

scPharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The Company's products administered subcutaneously through the sc2Wear Infusor. The Company’s pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via sc2Wear Infusor for diuresis in heart failure patients outside of the acute care setting. The Company has completed two pivotal clinical studies, four exploratory clinical studies, and 12 human factor studies for Furoscix, and scCeftriaxone an antibiotic used intravenously for the treatment of infections caused by gram-positive and gram-negative organisms.
More

Webull offers Scpharmaceuticals Inc (SCPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.